Literature DB >> 6691553

Surgical management of Crohn's disease involving the duodenum.

J J Murray, D J Schoetz, F W Nugent, J A Coller, M C Veidenheimer.   

Abstract

The experience with 25 patients who required operation for Crohn's disease involving the duodenum is reviewed. Two distinct patterns of duodenal involvement are apparent. Intrinsic duodenal Crohn's disease has a characteristic clinical presentation that is distinct from the symptoms seen in patients with involvement of other portions of the gastrointestinal tract. Among 70 patients with duodenal Crohn's disease seen over a 30 year period, 22 required surgical intervention at the Lahey Clinic. Although hemorrhage and intractable pain were associated problems in several of these patients, unrelenting duodenal obstruction remained the primary indication for operation. Of patients who underwent operative bypass, 78 percent had a good result with a median follow-up period of 12.3 years. The presence of associated gastric Crohn's disease did not influence long-term results. A third of the patients required reoperation for duodenal disease. Marginal ulceration and recurrent gastroduodenal obstruction have been the primary reasons for reoperation. Although the addition of vagotomy to operative bypass has not helped to protect against subsequent marginal ulceration, the absence of appreciable morbidity associated with vagotomy in our series and the high incidence of marginal ulcers reported with gastroenterostomy in other clinical settings lead us to recommend gastroenterostomy with vagotomy as the procedure of choice for duodenal Crohn's disease. Proceeding with vagotomy in persons who have had previous ileocecal or extensive small bowel resection should not be undertaken without careful consideration. Similar caution should also be used in patients who are already troubled with poorly controlled diarrhea. The duodenum may also be involved by duodenoenteric fistulas which represent a complication of Crohn's disease involving other portions of the gastrointestinal tract. Most frequently this occurs in patients with Crohn's colitis who have no evidence of intrinsic duodenal disease. Management of the internal fistula requires resection of the involved colon and closure of the duodenal defect. Three patients with duodenocolic fistula have been so treated.

Entities:  

Mesh:

Year:  1984        PMID: 6691553     DOI: 10.1016/0002-9610(84)90035-7

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  21 in total

1.  Severe stricturing Crohn's disease of the duodenum: A case report and review of surgical options.

Authors:  Jennifer M Racz; Ward Davies
Journal:  Int J Surg Case Rep       Date:  2012-03-23

2.  Gastroduodenal Crohn's disease.

Authors:  Costas H Kefalas
Journal:  Proc (Bayl Univ Med Cent)       Date:  2003-04

3.  Efficacy and Safety of Endoscopic Balloon Dilation for Upper Gastrointestinal Strictures of Crohn's Disease.

Authors:  Feilong Guo; Yuhua Huang; Weiming Zhu; Zhiming Wang; Lei Cao; Aoxue Chen; Zhen Guo; Yi Li; Jianfeng Gong; Jieshou Li
Journal:  Dig Dis Sci       Date:  2016-07-11       Impact factor: 3.199

4.  Benign duodenocolic fistula. A case presenting with acidosis.

Authors:  M Benn; F T Nielsen; H K Antonsen
Journal:  Dig Dis Sci       Date:  1997-02       Impact factor: 3.199

5.  Crohn's disease with gastroduodenal involvement: Diagnostic approach.

Authors:  Sachin B Ingle; Baban D Adgaonkar; Nawab P Jamadar; Saleha Siddiqui; Chitra R Hinge
Journal:  World J Clin Cases       Date:  2015-06-16       Impact factor: 1.337

Review 6.  Crohn's Disease of the Esophagus, Duodenum, and Stomach.

Authors:  David M Schwartzberg; Stephen Brandstetter; Alexis L Grucela
Journal:  Clin Colon Rectal Surg       Date:  2019-06-17

7.  Crohn's disease of the duodenum complicated by adenocarcinoma.

Authors:  M S Meiselman; G G Ghahremani; M W Kaufman
Journal:  Gastrointest Radiol       Date:  1987

8.  Strictureplasty.

Authors:  Sanjay Jobanputra; Eric G Weiss
Journal:  Clin Colon Rectal Surg       Date:  2007-11

9.  Pyloric stenosis associated Crohn's disease responding to adalimumab therapy.

Authors:  Sameer Gaggar; John Scott; Nicholas Thompson
Journal:  World J Gastrointest Pharmacol Ther       Date:  2012-12-06

10.  Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn's patients.

Authors:  Kweku A Appau; Victor W Fazio; Bo Shen; James M Church; Bret Lashner; Feza Remzi; Aaron Brzezinski; Scott A Strong; Jeffrey Hammel; Ravi P Kiran
Journal:  J Gastrointest Surg       Date:  2008-08-15       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.